Latest news
Gonorrhoea Is Learning To Beat Ceftriaxone. Europe Must Move First.
Ceftriaxone-resistant gonorrhoea is no longer only being imported into Europe. ECDC has found evidence of domestic transmission. The window to keep first-line treatment effective is still open, but it will close if testing and follow-up remain optional
COVID Vaccines Still Kept Adults Out of Hospital. The Evidence Should Matter.
Harlem’s Legionnaires’ Outbreak Was Not Just in the Air. It Was in the System.
Gene therapy is entering cardiology. Friedreich ataxia shows why rare heart disease may be the first test
Triglycerides are back in the spotlight. Europe is reviewing Sobi’s olezarsen for severe risk.
When Brain Surgery Is Too Risky, Patients Still Need a Molecular Answer
Kenya Moves to Keep Cancer From Bankrupting Families
Germany Is Paying the Price for Leaving Tardive Dyskinesia Behind
A Rare Childhood Ataxia Gets Real Phase III Evidence
Before a TB Vaccine Exists, Africa Is Building the Route to People
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.